Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
ImmusanT, Inc.
3125
ImmusanT, Inc.
Technology
Biotechnology
Immusan T is a biotechnology company focused on developing a treatment, and a set of diagnostic and monitoring tools to manage patients with celiac disease.
Suggest edits
Founded
2011
Raised
$20M
Follow us
Also headquartered in Cambridge
MIT
Raspberry Pi
ARM
Xconomy
Money Mover
Biogen
HubSpot
Formlabs
General Catalyst
Akamai
Companies in the same industry
Beijing Allcure Medical Technology
Eyevensys
Leukos Biotech
laboratoire MédiS
Antibodies.com
Patara Pharma, LLC
ADC Therapeutics
Vivo Biosciences Inc.
Paradigm Diagnostics
AudioCure Pharma GmbH
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Add round
11 Sep
2018
Undisclosed funding
JDRF T1D Fund
ImmusanT rakes in funding
PE HUB
13 Dec
2011
$20,000,000
Venture capital (Series A)
Vatera Healthcare Partners
